Literature DB >> 28888059

Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database.

Carla Carnovale1, Marta Gentili1, Stefania Antoniazzi2, Emilio Clementi3,4, Sonia Radice1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28888059     DOI： 10.1002/mus.25972

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  4 in total

1.  Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent.

Authors:  Nagehan Aslan; Dincer Yildizdas; Behruz Huseyınlı; Ozden Ozgur Horoz; Gulen Gul Mert; Faruk Ekinci; Duygu Ozcanyuz
Journal:  J Pediatr Intensive Care       Date:  2020-01-14

2.  Levetiracetam-induced rhabdomyolysis: the first Italian case.

Authors:  Eugenia Rota; Luciano Arena; Lorenzo Celli; Lucia Testa; Nicola Morelli
Journal:  Neurol Sci       Date:  2018-04-26       Impact factor: 3.307

3.  Effect of Levetiracetam Usage on Serum Creatine Phosphokinase Concentration in Patients with Epilepsy.

Authors:  Faruk Incecik; Ozlem M Herguner; Seyda Besen
Journal:  J Pediatr Neurosci       Date:  2020-06-27

Review 4.  Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review.

Authors:  Imran A Moinuddin
Journal:  Am J Case Rep       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.